Psychotropic agents in irritable bowel syndrome

Area of Science:

• Gastroenterology
• Psychiatry
• Pharmacology

Background:

• Irritable bowel syndrome (IBS) is a common gastrointestinal disorder.
• Neuromodulatory and analgesic effects of antidepressants are being explored for IBS treatment.
• Current IBS treatments may not be effective for all patients, particularly those with pain or psychological comorbidities.

Purpose of the Study:

• To review the evidence supporting the use of psychotropic agents in IBS management.
• To provide guidelines for optimizing medical management in specific IBS patient populations.

Main Methods:

• Review of existing literature on antidepressant use in IBS.
• Analysis of evidence for efficacy in pain management and psychological dysfunction.
• Synthesis of data to formulate clinical recommendations.

Main Results:

• Evidence supports the use of antidepressants in IBS patients with refractory pain.
• Psychotropic agents show efficacy in IBS patients with co-occurring psychological dysfunction.
• Non-antidepressant doses are often sufficient for symptom management.

Conclusions:

• Psychotropic agents are a viable option for specific IBS patient groups.
• Recommendations are provided to guide clinicians in optimizing IBS treatment.
• Further research may refine the role of these agents in IBS therapy.